StocksMarket.in

Tag "Cipla"

 Breaking News

Cipla seeks price hike for certain respiratory medications, writes to NPPA

Cipla spokesperson confirmed the development, and said the products impacted are a “small subset” of the overall basket of respiratory products. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”);

Read Full Article

Cipla: MA opportunity could be near-term trigger

Cipla, with its leadership in inhalation, focus on green chemistry and potential deployment of cash savings for new growth drivers, warrants attention Cipla | The company reported higher consolidated profit

Read Full Article

What should investors do with Cipla post Q1 earnings: buy, sell or hold?

The company reported a 25.41 percent increase in its consolidated net profit to Rs 709.92 crore for the quarter ended June 30, 2021 ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ //

Read Full Article

Buzzing Stocks: Rate-sensitives, Cipla, RIL and other stocks in news today

Stocks In the News: Check out the companies making the biggest headlines before the opening bell. Results on August 6 | Hindalco Industries, Mahindra & Mahindra, Aarti Industries, Abbott India,

Read Full Article

Cipla posts 24% YoY net profit growth in Q1FY22 led by core therapies, COVID portfolio

India business that includes branded formulations, trade generics and consumer health grew by 68% YoY to Rs 2,710 crore driven by volume growth in core therapies and support from existing

Read Full Article

Cipla share price gains on launching polymerase chain reaction test kit

ViraGen is Cipla’s third offering in the Covid-19 testing segment. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”);

Read Full Article

Cipla — While COVID scope continues, watch out for FY23

Just when it seemed that Covid tailwinds are waning for Cipla, the drug maker has repositioned itself for the opportunities

Read Full Article

Cipla share price down 3% after Q4 earnings misses expectations

Here’s what brokerages have to say about the stock and the company post Q4 results Cipla | Cipla (UK), wholly

Read Full Article

Buzzing Stocks: LT, Cipla, Bharti Airtel and others that will be in focus today

Check out the companies making the biggest headlines before the bell. Results on May 17 | Bharti Airtel, Federal Bank,

Read Full Article

Hot Stocks: Here#39;s why MGL, Maruti Suzuki Cipla are top stocks to buy on Friday

Support for the Nifty Index is placed at 14450 levels while resistance rests near 14950, says Patil. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]);

Read Full Article

Buzzing Stocks: Hero Moto, Cipla, Wipro and others that will be in focus today

Results on May 6: Hero MotoCorp, Adani Power, Adani Transmission, Apcotex Industries, Blue Star, Caplin Point Laboratories, Century Textiles &

Read Full Article

Roche#39;s COVID-19 antibody cocktail receives Emergency Use Authorisation, Cipla to distribute the drug

“The production process for this biologic medicine is very complex and Roche, as one of the largest biologics manufacturers in

Read Full Article

Buy Cipla: target of Rs 1100: Sharekhan

Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1100 in

Read Full Article

D-Street Buzz: Pharma stocks outperform led by Dr Reddy#39;s Labs; Cadila Health, Cipla, Glenmark hit new 52-week high

S&P BSE Healthcare gained over a percent with the top gainers being RPG Life Sciences which surged over 16 percent

Read Full Article

Trade Spotlight: What should investors do with Cipla, Dr Reddy’s Infosys?

Some of the stocks in focus were Dr Reddy’s Laboratories, which gained nearly 5 percent with strong volumes, Cipla that

Read Full Article

Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand

Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in

Read Full Article

Buy Cipla; target of Rs 950: Sharekhan

Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 950 in

Read Full Article

Pharma stocks rally after Rs 2.23 lakh-crore boost for healthcare sector; Cipla, Sun Pharma hit 52-week high

Source: AFP The Indian stock market is continuing its bull run for the third consecutive day with Nifty surging over

Read Full Article

Neutral Cipla; target of Rs 900: Motilal Oswal

Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 900 in its research report dated January

Read Full Article

Archives